LAM
HALO icon

LECAP Asset Management’s Halozyme HALO Stock Holding History

LECAP Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Sell
3,740
-3,609
-49% -$246K 0.13% 241
2026
Q1 		$475K Sell
7,349
-1,814
-20% -$128K 0.18% 197
2025
Q4 		$617K Buy
9,163
+1,200
+15% +$80.7K 0.25% 154
2025
Q3 		$584K Buy
+7,963
New +$529K 0.2% 189

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

LECAP Asset Management's HALO Position: Q2 2026 in Review

LECAP Asset Management reduced its Halozyme (HALO) stake by 49% in Q2 2026, selling an estimated $246K and leaving 3,740 shares worth $293K. The position accounts for 0.13% of the portfolio, ranked #241.

LECAP Asset Management first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. The position peaked at $617K in Q4 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • LECAP Asset Management held 3,740 shares of Halozyme worth $293K as of Q2 2026.
  • LECAP Asset Management sold 3,609 Halozyme shares in Q2 2026, an estimated $246K.
  • Halozyme made up 0.13% of LECAP Asset Management's portfolio in Q2 2026, its #241 holding.
  • LECAP Asset Management first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
  • LECAP Asset Management's Halozyme position peaked at $617K in Q4 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.